New Lifetime High Reached: Parexel International (PRXL)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Parexel International ( PRXL) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Parexel International as such a stock due to the following factors:

  • PRXL has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $36.1 million.
  • PRXL has traded 5,037 shares today.
  • PRXL is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PRXL with the Ticky from Trade-Ideas. See the FREE profile for PRXL NOW at Trade-Ideas

More details on PRXL:

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. PRXL has a PE ratio of 27.1. Currently there are 8 analysts that rate Parexel International a buy, 1 analyst rates it a sell, and 5 rate it a hold.

The average volume for Parexel International has been 537,600 shares per day over the past 30 days. Parexel International has a market cap of $3.3 billion and is part of the health care sector and health services industry. The stock has a beta of 1.20 and a short float of 6% with 8.46 days to cover. Shares are up 34.3% year-to-date as of the close of trading on Monday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

With Hurricane Harvey, We Are in the Crosshairs of Volatility: Market Recon

EY's Greene Sees More Med Tech, CRO Deals Ahead

Stocks Lower as Crude Oil Slides on Supply Concerns

Stock Futures Narrowly Mixed as Oil Plunges to Fresh 2017 Low